期刊文献+

Testosterone,cardiomyopathies,and heart failure:a narrative review 被引量:2

原文传递
导出
摘要 Testosterone exerts an important regulation of cardiovascular function through genomic and nongenomic pathways. It produces several changes in cardiomyocytes, the main actor of cardiomyopathies, which are characterized by pathological remodeling, eventually leading to heart failure. Testosterone is involved in contractility, in the energy metabolism of myocardial cells, apoptosis, and the remodeling process. In myocarditis, testosterone directly promotes the type of inflammation that leads to fibrosis, and influences viremia with virus localization. At the same time, testosterone exerts cardioprotective effects that have been observed in different studies. There is increasing evidence that low endogenous levels of testosterone have a negative impact in some cardiomyopathies and a protective impact in others. This review focuses on the interrelationships between testosterone and cardiomyopathies and heart failure.
出处 《Asian Journal of Andrology》 SCIE CAS CSCD 2021年第4期348-356,共9页 亚洲男性学杂志(英文版)
  • 相关文献

参考文献3

二级参考文献102

  • 1陈鑫,李昕,黄海艳,李希,林金芳.睾酮对胰岛素敏感细胞胰岛素受体底物1和葡萄糖转运载体4表达的影响[J].中华医学杂志,2006,86(21):1474-1477. 被引量:7
  • 2Wingard DL, Suarez L, Barrett-Conor E. The sex differential in mortality from all causes and ischaemic heart disease. Am J Epidemiol1983; l17: 165-72.
  • 3Njolstad I, Arnesen E, Lund-Larsen PG. Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study. Circulation 1996; 93: 450-6.
  • 4Kannel WB, Hjortland MC, McNamara PM, Gordon T. Menopause and risk of cardiovascular disease: The Framingham Study. Ann Intern Med 1976; 85: 447-52.
  • 5Kritz-Silverstein D, Barrett-Connor E, Wingard DL. Hysterectomy, oophorectomy, and heart disease risk factors in older women. Am J Public Health 1997; 87: 676-80.
  • 6Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE et at. Menopause and the risk of coronary heart disease in women. N EnglJ Med 1987; 316: 1105-10.
  • 7Misso ML, Murata Y, Boon WC, Jones ME, Britt KL et al. Cellular and molecular characterization of the adipose phenotype of the aromatase-deficient mouse. Endocrin%gy2003; 144: 1474-80.
  • 8La Vecchia C, Decarli A, Franceschi S, Gentile A, Negri E et at. Menstrual and reproductive factors and the risk 01 myocardial infarction in women under fifty-five years of age. Am J Obstet Gynecol1987; 157: 1108-12.
  • 9Hulley S, Grady D, Bush T, FurbergC, Herrington D et at. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogenlprogestin Replacement Study (HERS) Research Group. JAMA 1998; 280: 605-13.
  • 10Writing Group for the Womens Health Initiative. Risks and benefits of estrogen plus progestin in healthy postmenopauseal women. JAMA 2002; 288: 321-33.

共引文献14

同被引文献25

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部